Find verified Brilaroxazine API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Brilaroxazine for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Brilaroxazine API.
Alternate Names: brilaroxazina, brilaroxazinum
CAS No: 1239729-06-6
PubChem CID: 46861612
Mol Formula: C22H25Cl2N3O3
Mol Weight: 450.4 g/mol
IUPAC Name: 6-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-4H-1,4-benzoxazin-3-one
API Description: Brilaroxazine (RP5063) is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of schizophrenia and schizoaffective disorder. Reviva Pharmaceuticals also intends to investigate RP5063 for the treatment of bipolar disorder, major depressive disorder, psychosis/agitation associated with Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder (ADD/ADHD), and autism. As of May 2015, it is in phase III clinical trials for schizophrenia.
